| Literature DB >> 24303039 |
Gemma Monyarch1, Fernanda de Castro Reis, Jan-Paul Zock, Jesús Giraldo, Francisco Pozo-Rodríguez, Ana Espinosa, Gema Rodríguez-Trigo, Hector Verea, Gemma Castaño-Vinyals, Federico P Gómez, Josep M Antó, Maria Dolors Coll, Joan Albert Barberà, Carme Fuster.
Abstract
BACKGROUND: In a previous study, we showed that individuals who had participated in oil clean-up tasks after the wreckage of the Prestige presented an increase of structural chromosomal alterations two years after the acute exposure had occurred. Other studies have also reported the presence of DNA damage during acute oil exposure, but little is known about the long term persistence of chromosomal alterations, which can be considered as a marker of cancer risk.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24303039 PMCID: PMC3841120 DOI: 10.1371/journal.pone.0081276
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Frequency and types of chromosomal damage observed in standard culture.
|
|
| |
|---|---|---|
| Total individuals, No. | 91 | 46 |
| Total metaphases analyzed (uniform stain), No. | 9520 | 4859 |
| Total metaphases karyotyped (G-banded), No. | 2448 | 1285 |
|
| 100/9520 (1.05) | 35/4859 (0.72) |
| Gaps | 48 (0.5) | 19 (0.39) |
| Breaks | 52 (0.55) | 16 (0.33) |
|
| 196/2448 (8) | 33/1285 (2.56) |
|
| 12/196 (6.1) | 7/33 (21.2) |
| Reciprocal translocations | 10 | 7 |
| Robertsonian translocations | 2 | 0 |
|
| 184/196 (93.9) | 26/33(78.8) |
| Deletions | 23 | 6 |
| Deletions + acentric fragments | 9 | 3 |
| Acentric fragments | 42 | 0 |
| Imbalanced translocations | 23 | 3 |
| Dicentric translocations | 3 | 0 |
| Dicentric translocations+acentric fragment | 4 | 1 |
| Rings | 9 | 0 |
| Markers | 68 | 13 |
| Additional material of unknown origin | 2 | 0 |
| Isochromosomes | 1 | 0 |
|
| 203 | 61 |
| Chromosomal lesion (after G-banded) | 98 | 34 |
| Structural chromosomal alterations (G-banded) | 109 | 27 |
Figure 1Distribution of chromosome breakpoints observed in exposed (right) and non-exposed individuals (left) in the human ideogram (400-band resolution).
The most affected bands using the FSM statistical method are indicated by red arrows, and when using another statistical method that takes into account the relative length of chromosomal bands, by black arrows.
Chromosomal damage observed in E and NE individuals using uniform staining in cultures with aphidicolin vs standard culture.
| Culture with aphidicolin |
| Standard culture | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposed | Non-Exposed |
|
| Exposed | Non-Exposed |
| |||||||
|
| 14 | 14 | 14 | 14 | |||||||||
| Total metaphases analyzed | 1441 | 1410 | 1500 | 1463 | |||||||||
| Total metaphases with lesions (%) | 947/1441 (65.7) | 699/1410 (49.6) | 0.0141 | 12/1500 (0.8) | 8/1463 (0.5) | 0.4775 | |||||||
| Total metaphase with structural alterations No./total (%) | 46/1441 (3.2) | 16/1410 (1.1) | 0.0376 | 15/1500 (0.01) | 1/1463 (0.07) | 0.0594 | |||||||
|
| 1864/1441 (129.3) | 1216/1410 (86.2) | 0.0231 | 13/1500 (0.9) | 10/1463 (0.7) | 0.6455 | |||||||
| Gaps | 1007 | 623 | 6 | 6 | |||||||||
| Chromatid gap | 496 | 346 | 5 | 6 | |||||||||
| Chromosome gap | 511 | 277 | 1 | 0 | |||||||||
| Breaks | 857 | 593 | 7 | 4 | |||||||||
| Chromatid break | 239 | 107 | 5 | 2 | |||||||||
| Chromosome break | 618 | 487 | 2 | 2 | |||||||||
|
| 63/1441 (4.4) | 19/1410 (1.4) | 0.0239 | 24/1500 (1.6) | 1/1463 (0.07) | 0.0791 | |||||||
|
| |||||||||||||
| Translocations | 7 | 2 | 0 | 0 | |||||||||
|
| |||||||||||||
| Deletions | 12 | 0 | 0 | 0 | |||||||||
| Acentric fragments | 11 | 3 | 16 | 1 | |||||||||
| Imbalanced translocations | 9 | 0 | 0 | 0 | |||||||||
| Dicentric translocations | 15 | 12 | 0 | 0 | |||||||||
| Rings | 7 | 1 | 2 | 0 | |||||||||
| Markers | 1 | 1 | 6 | 0 | |||||||||
| Duplications | 1 | 0 | 0 | 0 | |||||||||
|
| 1927/1441 (1.33) | 1235/1410 (0.87) | 0.0161 | 37/1500 (0.025) | 11/1500 (0.07) | 0.1080 | |||||||
Chromosomal bands most affected in present study, genes and recurrent chromosomal reorganization present in hematopoietic malignances, and comparising with chronic benzene exposure.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| T-Cell lymphoma | No | [ |
|
| Chronic lymphocytic leukemia (CLL) | No | [ | |||||
|
|
|
|
|
|
| T-Cell lymphoma | No | [ |
| Non-Hodgkin lymphoma (NHL) | No | [ | ||||||
|
|
|
|
|
|
| Acute lymphoblastic leukemia (ALL) | No | [ |
|
|
| Myelodysplastic Syndrome (MDS) | Yes | [ | ||||
|
| Chronic myelomonocytic leukemia (CMML) | No | [ | |||||
| Myelodysplastic Syndrome | No | [ | ||||||
| Acute myeloid leukemia (AML) and myelodysplastic Syndrome (MDS) | No | [ | ||||||
| Acute lymphoblastic leukemia (ALL) | No | [ | ||||||
|
| - | - | - | - | - | Leukemogenesis (ALL and AML) | No | [ |
| Acute lymphoblastic leukemia (ALL) | No | [ | ||||||
| Acute lymphoblastic leukemia (ALL) | Yes | [ | ||||||
| Acute lymphoblastic leukemia (ALL) | No | [ | ||||||
|
| - | - | - | - | - | Acute myeloid leukemia (AML) | Yes | [ |